首页> 美国卫生研究院文献>Saudi Journal of Medicine Medical Sciences >Acute Bacterial Endophthalmitis Following Dexamethasone Intravitreal Implant: A Case Report
【2h】

Acute Bacterial Endophthalmitis Following Dexamethasone Intravitreal Implant: A Case Report

机译:地塞米松玻璃体内植入术后急性细菌性眼内炎:一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 54-year-old male presented to our ophthalmology clinic with a diagnosis of the right central retinal vein occlusion with macular edema. The patient was treated with dexamethasone intravitreal implant. Three days after the implant insertion, the patient experienced pain, redness and blurred vision in the same eye. With a provisional diagnosis of acute endophthalmitis, a combination of ceftazidime 2.25 mg/0.1 ml and vancomycin 1 mg/0.1 ml was injected intravitreally. One week after the treatment, endophthalmitis signs and symptoms subsided. This report presents a case of endophthalmitis following dexamethasone intravitreal implant, with a favorable outcome after treatment with intravitreal antibiotic injection without removal of the implant.
机译:一名54岁的男性出现在我们的眼科诊所,诊断为视网膜中央中央静脉阻塞并伴有黄斑水肿。该患者接受地塞米松玻璃体内植入物治疗。植入物植入三天后,患者的同一只眼睛出现疼痛,发红和视力模糊。初步诊断为急性眼内炎,玻璃体内注射头孢他啶2.25 mg / 0.1 ml和万古霉素1 mg / 0.1 ml的组合。治疗一周后,眼内炎症状和体征消退。该报告介绍了地塞米松玻璃体内植入物植入后发生眼内炎的病例,经玻璃体内抗生素注射治疗但未移出植入物,结果良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号